I agree that this site is using cookies. You can find further informations here.
X
Lainchbury, Michael
17  results:
Search for persons X
?
1

Fragment screening at AstraZeneca: developing the next gene..:

Lucas, Simon C. C. ; Börjesson, Ulf ; Bostock, Mark J....
RSC Medicinal Chemistry.  13 (2022)  9 - p. 1052-1057 , 2022
Link: https://doi.org/10.1039/..
 
?
2

Discovery of Spiro-azaindoline Inhibitors of Hematopoietic ..:

Chan, Bryan K. ; Seward, Eileen ; Lainchbury, Michael...
ACS Medicinal Chemistry Letters.  13 (2021)  1 - p. 84-91 , 2021
Link: https://doi.org/10.1021/..
 
?
3

Correction to Noncovalent Mutant Selective Epidermal Growth..:

Heald, Robert ; Bowman, Krista K. ; Bryan, Marian C....
Journal of Medicinal Chemistry.  59 (2016)  6 - p. 2848-2848 , 2016
Link: https://doi.org/10.1021/..
 
?
4

Discovery of a Noncovalent, Mutant-Selective Epidermal Grow..:

Chan, Bryan K. ; Hanan, Emily J. ; Bowman, Krista K....
Journal of Medicinal Chemistry.  59 (2016)  19 - p. 9080-9093 , 2016
Link: https://doi.org/10.1021/..
 
?
5

Multiparameter Lead Optimization to Give an Oral Checkpoint..:

Osborne, James D. ; Matthews, Thomas P. ; McHardy, Tatiana...
Journal of Medicinal Chemistry.  59 (2016)  11 - p. 5221-5237 , 2016
Link: https://doi.org/10.1021/..
 
?
6

Noncovalent Mutant Selective Epidermal Growth Factor Recept..:

Heald, Robert ; Bowman, Krista K. ; Bryan, Marian C....
Journal of Medicinal Chemistry.  58 (2015)  22 - p. 8877-8895 , 2015
Link: https://doi.org/10.1021/..
 
?
7

The clinical development candidate CCT245737 is an orally a..:

Walton, Mike I. ; Eve, Paul D. ; Hayes, Angela...
Oncotarget.  7 (2015)  3 - p. 2329-2342 , 2015
Link: https://doi.org/10.18632..
 
?
8

Pyridones as Highly Selective, Noncovalent Inhibitors of T7..:

Bryan, Marian C. ; Burdick, Daniel J. ; Chan, Bryan K....
ACS Medicinal Chemistry Letters.  7 (2015)  1 - p. 100-104 , 2015
Link: https://doi.org/10.1021/..
 
?
9

Discovery of Selective and Noncovalent Diaminopyrimidine-Ba..:

Hanan, Emily J. ; Eigenbrot, Charles ; Bryan, Marian C....
Journal of Medicinal Chemistry.  57 (2014)  23 - p. 10176-10191 , 2014
Link: https://doi.org/10.1021/..
 
?
10

Discovery of 3-Alkoxyamino-5-(pyridin-2-ylamino)pyrazine-2-..:

Lainchbury, Michael ; Matthews, Thomas P. ; McHardy, Tatiana...
Journal of Medicinal Chemistry.  55 (2012)  22 - p. 10229-10240 , 2012
Link: https://doi.org/10.1021/..
 
?
11

A Protecting Group Free Synthesis of (±)-Neostenine via the..:

Lainchbury, Michael D. ; Medley, Marcus I. ; Taylor, Piers M....
The Journal of Organic Chemistry.  73 (2008)  17 - p. 6497-6505 , 2008
Link: https://doi.org/10.1021/..
 
?
12

Fragment screening at AstraZeneca: developing the next gene..:

Lucas, Simon C. C ; Börjesson, Ulf ; Bostock, Mark J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491351/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
13

Discovery of Spiro-azaindoline Inhibitors of Hematopoietic ..:

Chan, Bryan K ; Seward, Eileen ; Lainchbury, Michael...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762754/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
14

Discovery of Selective and Noncovalent Diaminopyrimidine-Ba..:

Hanan, Emily J ; Eigenbrot, Charles ; Bryan, Marian C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266342/.  , 2014
Link: http://www.ncbi.nlm.nih...
 
?
15

CCT244747 is a novel, potent and selective CHK1 inhibitor w..:

Walton, Mike I ; Eve, Paul D ; Hayes, Angela...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474704.  , 2012
Link: http://www.ncbi.nlm.nih...
 
1-15